TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6742382

Group type: EXPERIMENTAL
Intervention: 0.5% lignocaine with adrenaline 1:200 000
Number of subjects: 19

Group type: COMPARATOR
Intervention: prilocaine 0.5% with octapressin 0.03 iu per ml
Number of subjects: 19
Study: 31785093

Group type: EXPERIMENTAL
Intervention: Second harmonic generation (SHG) microscopy and optical scattering measurements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wavelength‐dependent optical scattering measurements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SHG circular dichroism
Number of subjects: 0
Study: 29615058

Group type: EXPERIMENTAL
Intervention: recombinant human growth hormone (rhGH) treatment
Number of subjects: 43
Study: 26266260

Group type: EXPERIMENTAL
Intervention: Vaginal Zataria multiflora cream
Number of subjects: 420

Group type: COMPARATOR
Intervention: Oral metronidazole pill
Number of subjects: 420
Study: 23396375

Group type: EXPERIMENTAL
Intervention: Newly developed generic formulation of S-1 (40 mg/m(2), po)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Branded reference formulation of S-1 (40 mg/m(2), po)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both formulations of S-1
Number of subjects: 30
Study: 21922361

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (IIT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventional treatment (CT)
Number of subjects: 25
Study: 19519724

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (8 mg/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 17449541

Group type: EXPERIMENTAL
Intervention: Test protocol (7 days' training with exercise and neck suction)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control protocol (exercise alone)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control protocol (neck suction alone)
Number of subjects: 8
Study: 15096532

Group type: EXPERIMENTAL
Intervention: Written emotional disclosure intervention (writing about traumas and stressors for 20 minutes on three different days)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (writing about summer activities for 20 minutes on three different days)
Number of subjects: 54
Study: 11673220

Group type: EXPERIMENTAL
Intervention: Sibling pairs
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Smoking-concordant sibling pairs
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Smoking-discordant siblings
Number of subjects: 392
Study: 9551002

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention including behavioral curricula, parental involvement, school food service changes, and industry support.
Number of subjects: 20
Study: 8794428

Group type: EXPERIMENTAL
Intervention: Hormonal replacement treatment (HRT) with transdermal 17 beta‐estradiol, 50 mg/day for 24 days/month and medroxiprogesterone, 10 mg for 12 days
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Calcium treatment with elemental calcium, 1 g/day
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Eel calcitonin treatment with 40 IU/day for 10 days/month and elemental calcium, 500 mg/day
Number of subjects: 104

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 104
Study: 2517009

Group type: EXPERIMENTAL
Intervention: Rilmenidine (1 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 814955

Group type: EXPERIMENTAL
Intervention: 0.5% silver nitrate compresses (SN)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1% silver sulphadiazine cream (SSD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.5% silver nitrate and 0.2% chlorhexidine digluconate cream (SNC)
Number of subjects: 0
Study: 30702370

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) for 6 weeks with inspiratory loads of 80% of sustained maximal inspiratory pressure (n = 9)
Number of subjects: 14

Group type: COMPARATOR
Intervention: SHAM protocol for 6 weeks with inspiratory loads of 30% of sustained maximal inspiratory pressure (n = 5)
Number of subjects: 14
Study: 27779195

Group type: EXPERIMENTAL
Intervention: CTC interpreted by gastroenterologists
Number of subjects: 1257

Group type: COMPARATOR
Intervention: CTC interpreted by radiologists
Number of subjects: 1257

Group type: COMPARATOR
Intervention: CTC interpretation time by radiologists
Number of subjects: 1257

Group type: EXPERIMENTAL
Intervention: CTC interpretation time by gastroenterologists
Number of subjects: 1257

Group type: EXPERIMENTAL
Intervention: CTC for pedunculated and sessile lesions
Number of subjects: 1257

Group type: EXPERIMENTAL
Intervention: CTC for flat elevated lesions ≥10 mm
Number of subjects: 1257
Study: 26119844

Group type: EXPERIMENTAL
Intervention: Calcium plus vitamin D supplementation (1000 mg calcium daily plus 50000 IU vitamin D weekly)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Calcium alone (1000 mg daily)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Vitamin D alone (50000 IU weekly)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo (calcium placebo daily plus vitamin D placebo weekly)
Number of subjects: 104
Study: 24354968

Group type: EXPERIMENTAL
Intervention: Regular heroin use prior to imprisonment
Number of subjects: 425

Group type: COMPARATOR
Intervention: Non-regular heroin use (control group)
Number of subjects: 425
Study: 21757915

Group type: EXPERIMENTAL
Intervention: Cholecystectomy
Number of subjects: 137

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 137
Study: 19224680

Group type: EXPERIMENTAL
Intervention: Dialogic citizenship education curriculum units
Number of subjects: 482

Group type: COMPARATOR
Intervention: Regular history classes
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Curriculum unit with more group work
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Curriculum unit with less group work (whole-class teaching)
Number of subjects: 482
Study: 16785331

Group type: EXPERIMENTAL
Intervention: valsartan (80 to 160 mg)
Number of subjects: 28

Group type: COMPARATOR
Intervention: atenolol (50 to 100 mg)
Number of subjects: 28
Study: 15280154

Group type: EXPERIMENTAL
Intervention: Acipimox (250 mg orally four times daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lean women
Number of subjects: 20
Study: 12004668

Group type: EXPERIMENTAL
Intervention: Condensable composite resin with flowable composite resin as a liner
Number of subjects: 0

Group type: COMPARATOR
Intervention: Condensable composite resin without flowable composite resin as a liner
Number of subjects: 0
Study: 9869984

Group type: EXPERIMENTAL
Intervention: Fixed power at 32 watts
Number of subjects: 120

Group type: COMPARATOR
Intervention: Temperature monitoring with a target temperature of 60 degrees C
Number of subjects: 120
Study: 8306661

Group type: EXPERIMENTAL
Intervention: Group A (donor-recipient corneal size difference of 0.25 mm)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Group B (donor-recipient corneal size difference of 0.50 mm)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Group A
Number of subjects: 38

Group type: COMPARATOR
Intervention: Group B
Number of subjects: 38
Study: 3103761

Group type: EXPERIMENTAL
Intervention: Slow Sodium tablets (100 mmol sodium chloride)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 15
Study: 31268376

Group type: EXPERIMENTAL
Intervention: Sarilumab 150 mg q2w
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Sarilumab 200 mg q2w
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Sarilumab 150 mg q2w + csDMARDs
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Sarilumab 200 mg q2w + csDMARDs
Number of subjects: 91
Study: 28756691

Group type: EXPERIMENTAL
Intervention: Word-web intervention (n=11)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Waiting control (n=9)
Number of subjects: 20
Study: 26514790

Group type: EXPERIMENTAL
Intervention: Veterans' In-home Program (VIP) consisting of 6 home visits and 2 telephone calls delivered by occupational therapists over a 3-4 month period.
Number of subjects: 81

Group type: COMPARATOR
Intervention: Enhanced usual care (control group)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Veterans' In-home Program (VIP)
Number of subjects: 81
Study: 26603250

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioural therapy (CBT)
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Behaviour therapy (BT)
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Non‐directive supportive therapy (NDST)
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: All interventions (CBT, BT, MI, NDST)
Number of subjects: 297
Study: 22596014

Group type: EXPERIMENTAL
Intervention: Combined ω3 and ω6 supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21119407

Group type: EXPERIMENTAL
Intervention: Workshop group (WG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonworkshop group (NWG)
Number of subjects: 0
Study: 18534136

Group type: EXPERIMENTAL
Intervention: Combination pharmacological cardioversion therapy with low‐dose oral amiodarone (2 mg/kg), captopril (0.25 mg/kg), and simvastatin (0.3 mg/kg) administered daily
Number of subjects: 99

Group type: COMPARATOR
Intervention: Only ventricular heart rate control
Number of subjects: 99
Study: 15777447

Group type: EXPERIMENTAL
Intervention: Microwave endometrial ablation (MEA)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Transcervical resection of the endometrium (TCRE)
Number of subjects: 239
Study: 12450897

Group type: EXPERIMENTAL
Intervention: 1 mmol glycine/kg lean body mass
Number of subjects: 9

Group type: COMPARATOR
Intervention: 25 g glucose
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 1 mmol glycine/kg lean body mass + 25 g glucose
Number of subjects: 9

Group type: COMPARATOR
Intervention: Water only
Number of subjects: 9
Study: 10512559

Group type: EXPERIMENTAL
Intervention: Low-fat diet intervention (group sessions weekly for 6 weeks, biweekly for 6 weeks, and monthly for 9 months)
Number of subjects: 1702

Group type: EXPERIMENTAL
Intervention: Low-fat diet intervention
Number of subjects: 1702
Study: 8745134

Group type: EXPERIMENTAL
Intervention: Bupropion HCL (300 mg/day)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study: 2029827

Group type: EXPERIMENTAL
Intervention: Allopurinol riboside, 25 mg/kg q.i.d. for 13 doses
Number of subjects: 32

Group type: COMPARATOR
Intervention: Allopurinol riboside
Number of subjects: 32
Study: 6988914

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: DES
Number of subjects: 343

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 343
Study: 30793537

Group type: EXPERIMENTAL
Intervention: Pain Assessment and Analysis System (PAAS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no PAAS)
Number of subjects: 24
Study: 28631923

Group type: EXPERIMENTAL
Intervention: Flavonoid-rich supplement (329 mg/d)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Flavonoid-rich supplement
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 26098966

Group type: EXPERIMENTAL
Intervention: Grafts procured from donors older than 60 years
Number of subjects: 9724

Group type: EXPERIMENTAL
Intervention: Grafts from donors with a history of diabetes
Number of subjects: 9724

Group type: EXPERIMENTAL
Intervention: Grafts from donors with a body mass index of 35 kg/m(2) or more
Number of subjects: 9724

Group type: EXPERIMENTAL
Intervention: Grafts from donors with severe graft steatosis (more than 60 per cent)
Number of subjects: 9724

Group type: EXPERIMENTAL
Intervention: Grafts from donation after cardiac death donors with prolonged warm ischaemia
Number of subjects: 9724
Study: 24055998

Group type: EXPERIMENTAL
Intervention: Twice a week assessment of home spirometry and CF respiratory symptoms using an electronic device
Number of subjects: 320

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 320
Study: 21335941

Group type: EXPERIMENTAL
Intervention: Lidocaine suppository (60 mg)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Glycerin suppository (placebo)
Number of subjects: 160
Study: 19686930

Group type: EXPERIMENTAL
Intervention: Full-thickness flap reflection
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Partial-thickness flap reflection
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Osteoperiosteal flaps (book flap)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Full-thickness flaps
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Overall results of the three flap approaches
Number of subjects: 40
Study: 17471064

Group type: EXPERIMENTAL
Intervention: Sham analgesic cream
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Inactive cream
Number of subjects: 31

Group type: COMPARATOR
Intervention: Inactive cream (control)
Number of subjects: 31
Study: 15190832

Group type: EXPERIMENTAL
Intervention: Biological organic zinc after routine antibiotic treatment
Number of subjects: 61

Group type: COMPARATOR
Intervention: Routine antibiotic treatment only
Number of subjects: 61
Study: 12370217

Group type: EXPERIMENTAL
Intervention: ezetimibe (10 mg/d)
Number of subjects: 18

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 18
Study: 9647029

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg twice daily for 7 days
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 8164924

Group type: EXPERIMENTAL
Intervention: NORPLANT implants
Number of subjects: 10718
Study: 2504265

Group type: EXPERIMENTAL
Intervention: Extradural fentanyl 50 micrograms
Number of subjects: 27

Group type: COMPARATOR
Intervention: Intravenous fentanyl 50 micrograms
Number of subjects: 27

Group type: COMPARATOR
Intervention: Lignocaine and adrenaline alone (no fentanyl)
Number of subjects: 27
Study: 1252358

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Histamine and papain
Number of subjects: 0
Study: 31344296

Group type: EXPERIMENTAL
Intervention: HPC-NL
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: HPC-NL + B (10 mg/daily)
Number of subjects: 50
Study: 28013124

Group type: EXPERIMENTAL
Intervention: Positive affect measured after remission
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Negative affect measured after remission
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Comparison of affect with number of previous depressive episodes
Number of subjects: 107
Study: 26167637

Group type: EXPERIMENTAL
Intervention: Early high-volume hemofiltration (HVHF) at 80 ml/kg/h for 48 hours
Number of subjects: 224

Group type: COMPARATOR
Intervention: Control (standard care with delayed CVVHDF for persistent severe acute kidney injury)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Early high-volume hemofiltration (HVHF)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 224
Study: 24011983

Group type: EXPERIMENTAL
Intervention: Cognitive training
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: Reminiscence therapy
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: Individualized cognitive rehabilitation program
Number of subjects: 653

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: Cognitive abilities
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: Functional abilities in activities of daily living
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: Behavioral disturbance
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: Apathy
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: Quality of life
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: Caregiver's burden
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: Resource utilization
Number of subjects: 653
Study: 20434290

Group type: EXPERIMENTAL
Intervention: Chronic Care Model (CCM) intervention
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Insulin use
Number of subjects: 119

Group type: COMPARATOR
Intervention: Medication treatment intensification (TI)
Number of subjects: 119
Study: 18249160

Group type: EXPERIMENTAL
Intervention: Hypertonic saline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 15872238

Group type: EXPERIMENTAL
Intervention: Valacyclovir (2 g twice on the day of treatment and 1 g twice the following day)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study: 12517199

Group type: EXPERIMENTAL
Intervention: Nebulizer group (received nebulized albuterol)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Spacer group (received albuterol by metered-dose inhaler with a spacer)
Number of subjects: 168
Study: 11404902

Group type: EXPERIMENTAL
Intervention: Powder-free glove A
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Powder-free glove B
Number of subjects: 10

Group type: COMPARATOR
Intervention: Both gloves
Number of subjects: 10
Study: 8867518

Group type: EXPERIMENTAL
Intervention: Apomorphine infusion (low, medium, high rates)
Number of subjects: 8
Study: 1612153

Group type: COMPARATOR
Intervention: Room air breathing
Number of subjects: 26

Group type: COMPARATOR
Intervention: Hypoxic mixture
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 15% oxygen
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 21% oxygen
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 30% oxygen
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 100% oxygen
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Normoxic and hyperoxic conditions
Number of subjects: 26
Study: 6200724

Group type: EXPERIMENTAL
Intervention: Intravenous isosorbide dinitrate infusion (50-200 micrograms/kg/h)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Intravenous hydralazine bolus (0.15 mg/kg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Combination of isosorbide dinitrate and hydralazine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control measurements (1 h)
Number of subjects: 18
Study: 29973229

Group type: EXPERIMENTAL
Intervention: mHealth decision support system (early-access arm)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Usual care (later-access arm)
Number of subjects: 44
Study: 26474989

Group type: EXPERIMENTAL
Intervention: S-1 and oxaliplatin (SOX) therapy
Number of subjects: 663

Group type: COMPARATOR
Intervention: S-1 and cisplatin (CS) therapy
Number of subjects: 663
Study: 24958362

Group type: EXPERIMENTAL
Intervention: Flow-inflating resuscitators (FIR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-inflating resuscitators (SIR)
Number of subjects: 0
Study: 22893765

Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic and resistance exercise training (n = 27)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Low-intensity stretching control treatment (n = 16)
Number of subjects: 43
Study: 20479483

Group type: EXPERIMENTAL
Intervention: CE+
Number of subjects: 14

Group type: COMPARATOR
Intervention: PLA
Number of subjects: 14

Group type: COMPARATOR
Intervention: CE
Number of subjects: 14
Study: 19094450

Group type: EXPERIMENTAL
Intervention: Intravenous supplementation with glutamine dipeptide (Gln) 30 g/day
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard amino acid mixture (control) 25 g/day
Number of subjects: 16
Study: 16052023

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 14688685

Group type: EXPERIMENTAL
Intervention: Lower-hematocrit strategy (21.5% ± 2.9%)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Higher-hematocrit strategy (27.8% ± 3.2%)
Number of subjects: 147
Study: 10939064

Group type: EXPERIMENTAL
Intervention: Listening to Mozart for 10 minutes
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Listening to Bach for 10 minutes
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (no music)
Number of subjects: 61
Study: 9079575

Group type: EXPERIMENTAL
Intervention: Culturally specific obesity prevention program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention placebo group
Number of subjects: 0
Study: 8416561

Group type: EXPERIMENTAL
Intervention: Nonionic low-osmolality contrast medium (iopamidol)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Ionic high-osmolality contrast medium (sodium diatrizoate)
Number of subjects: 70
Study: 3519233

Group type: EXPERIMENTAL
Intervention: High-dose dexamethasone
Number of subjects: 40

Group type: COMPARATOR
Intervention: High-dose metoclopramide
Number of subjects: 40
Study: 31613134

Group type: EXPERIMENTAL
Intervention: Parents of an adult with SMI
Number of subjects: 6084

Group type: COMPARATOR
Intervention: Parents of an adult child with DD
Number of subjects: 6084

Group type: EXPERIMENTAL
Intervention: Parental ambivalence
Number of subjects: 6084
Study: 29509892

Group type: EXPERIMENTAL
Intervention: Video-assisted thoracoscopic surgery (VATS) with resection of bullae/blebs and mechanical pleurodesis
Number of subjects: 181

Group type: COMPARATOR
Intervention: Conventional chest tube treatment
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Video-assisted thoracoscopic surgery (VATS) for bullae ≥1 cm
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Size-response relationship for bullae
Number of subjects: 181
Study: 27912950

Group type: EXPERIMENTAL
Intervention: aYPFS plus montelukast
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo plus montelukast
Number of subjects: 57
Study: 24803369

Group type: EXPERIMENTAL
Intervention: Lexicalized conceptual metaphors
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Novel conceptual metaphors
Number of subjects: 13

Group type: COMPARATOR
Intervention: Typically developing (TD) controls
Number of subjects: 13
Study: 22313550

Group type: EXPERIMENTAL
Intervention: QTc by Bazett's formula (QTcB)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: QTc by Fridericia's method (QTcF)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Between‐subject variability in QTcF
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Within‐subject variability in QTcF
Number of subjects: 207
Study: 20634469

Group type: EXPERIMENTAL
Intervention: Parent-based add-on component (Raising Smoke-Free Kids)
Number of subjects: 1386

Group type: COMPARATOR
Intervention: TNT-only condition (control)
Number of subjects: 1386
Study: 19803312

Group type: EXPERIMENTAL
Intervention: 100 mcg of intravenous fentanyl
Number of subjects: 170

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Fentanyl pretreatment
Number of subjects: 170